The McKesson RxOTM team has identified five trends it believes will affect hospital and health system pharmacies in the coming year. These five trends are: renewed interest in the 340B Drug Pricing Program to address growing oversight and reimbursement changes, access to data and analytics to drive outcomes and operational efficiency, continued growth in the specialty pharmaceuticals market, health system pharmacies generating revenue, and consolidation driving centralized service centers. "As value-based care models continue to gain greater acceptance, hospital and health system pharmacies are increasingly charged with generating revenue and improving savings that contribute to the system's bottom line," said Mark Eastham, senior vice president and general manager, McKesson RxO. "Renewed interest in 340B, the continued growth of specialty, and the ability to leverage data and analytics to drive outcomes and operational efficiencies are some of the key trends and opportunities facing health system pharmacies in the coming year." McKesson will discuss these trends at the American Society of Health-System Pharmacists Midyear Clinical Meeting 2017.